Prospective multicenter trial to assess the effectiveness and safety of pulse methylprednisolone combined with intravenous immunoglobulin (IVIG) as a primary treatment in patients with acute Kawasaki Disease
Not Applicable
- Conditions
- Acute Kawasaki Disease
- Registration Number
- JPRN-UMIN000009946
- Lead Sponsor
- the Osaka Kawasaki Dieaase Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 418
Inclusion Criteria
Not provided
Exclusion Criteria
1) coronary artery lesions found before treatments 2) addisional underlying diseases other than Kawasaki disease 3) unsuitable patients considered by doctor in charge
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction of fervescence period, improvement of laboratory tests, frequency of adverse events
- Secondary Outcome Measures
Name Time Method frequency and severity of coronary arterial lesions in acute phase and long-term prognosis